化可触发I型干扰素依赖的抗瘤免疫,并增强免疫治疗在肺癌中的疗效

Chuanjia Gu1,2,3, Xue Wang4, Kaiyu Wang4,5

  • 1Department of Respiratory Endoscopy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

概括

化可增强非小细胞肺癌 (NSCLC) 的抗瘤免疫力,通过增加CD8+T细胞和重新编程免疫微环境. 结合冷和PD-1阻断,在小鼠模型和患者中都显示出协同效果.